Pier‐Luigi Lollini

12.7k total citations
254 papers, 10.0k citations indexed

About

Pier‐Luigi Lollini is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Pier‐Luigi Lollini has authored 254 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Immunology, 107 papers in Oncology and 100 papers in Molecular Biology. Recurrent topics in Pier‐Luigi Lollini's work include Immunotherapy and Immune Responses (100 papers), Sarcoma Diagnosis and Treatment (49 papers) and Monoclonal and Polyclonal Antibodies Research (44 papers). Pier‐Luigi Lollini is often cited by papers focused on Immunotherapy and Immune Responses (100 papers), Sarcoma Diagnosis and Treatment (49 papers) and Monoclonal and Polyclonal Antibodies Research (44 papers). Pier‐Luigi Lollini collaborates with scholars based in Italy, United States and France. Pier‐Luigi Lollini's co-authors include Patrizia Nanni, Carla De Giovanni, Giordano Nicoletti, Guido Forni, Lorena Landuzzi, Katia Scotlandi, Federica Cavallo, Piero Musiani, Maria Cristina Manara and Emma Di Carlo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Pier‐Luigi Lollini

250 papers receiving 9.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pier‐Luigi Lollini Italy	56	4.4k	4.0k	3.8k	1.9k	1.3k	254	10.0k
Alexander Eggermont Netherlands	59	4.1k 0.9×	5.3k 1.3×	5.7k 1.5×	1.4k 0.7×	721 0.5×	218	11.9k
Keith L. Knutson United States	55	4.7k 1.1×	6.7k 1.7×	6.4k 1.7×	1.4k 0.8×	1.6k 1.3×	187	14.3k
Peter J.K. Kuppen Netherlands	60	3.6k 0.8×	3.4k 0.8×	5.4k 1.4×	1.7k 0.9×	844 0.6×	313	11.9k
Patrizia Nanni Italy	48	2.8k 0.6×	2.6k 0.6×	2.5k 0.7×	1.1k 0.6×	910 0.7×	171	6.5k
Barbara Seliger Germany	65	5.3k 1.2×	8.1k 2.0×	6.3k 1.6×	1.4k 0.7×	822 0.6×	362	15.2k
Elda Tagliabue Italy	60	6.8k 1.5×	2.5k 0.6×	5.4k 1.4×	1.4k 0.7×	2.2k 1.7×	259	13.0k
Alessandro D. Santin United States	53	3.2k 0.7×	2.4k 0.6×	4.6k 1.2×	1.5k 0.8×	1.3k 1.0×	353	10.6k
Jonathan Cebon Australia	62	4.7k 1.1×	6.6k 1.6×	6.3k 1.6×	1.2k 0.6×	561 0.4×	278	13.6k
Donald J. Buchsbaum United States	51	4.8k 1.1×	1.4k 0.3×	3.4k 0.9×	1.1k 0.6×	1.9k 1.4×	281	9.2k
Hans Schreiber United States	54	3.6k 0.8×	7.9k 2.0×	6.7k 1.7×	1.3k 0.7×	1.0k 0.8×	252	13.1k

Countries citing papers authored by Pier‐Luigi Lollini

Since Specialization

Citations

This map shows the geographic impact of Pier‐Luigi Lollini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pier‐Luigi Lollini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pier‐Luigi Lollini more than expected).

Fields of papers citing papers by Pier‐Luigi Lollini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pier‐Luigi Lollini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pier‐Luigi Lollini. The network helps show where Pier‐Luigi Lollini may publish in the future.

Co-authorship network of co-authors of Pier‐Luigi Lollini

This figure shows the co-authorship network connecting the top 25 collaborators of Pier‐Luigi Lollini. A scholar is included among the top collaborators of Pier‐Luigi Lollini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pier‐Luigi Lollini. Pier‐Luigi Lollini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palladini, Arianna, Patrizia Nanni, Louise Goksøyr, et al.. (2025). Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma. Journal of Translational Medicine. 23(1). 136–136. 3 indexed citations

Riccardo, Federica, Laura Conti, Lidia Tarone, et al.. (2024). Cancer vaccines: Target antigens, vaccine platforms and preclinical models. Molecular Aspects of Medicine. 101. 101324–101324. 14 indexed citations

Landuzzi, Lorena, et al.. (2024). IL-1 Family Members in Bone Sarcomas. Cells. 13(3). 233–233. 7 indexed citations

Nanni, Patrizia, et al.. (2024). Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay. Methods in cell biology. 190. 75–86. 1 indexed citations

Laginestra, Maria Antonella, Caterina Mancarella, Lorena Landuzzi, et al.. (2021). Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma. Cancer Research. 82(4). 708–720. 16 indexed citations

Guerzoni, Clara, Maria Cristina Manara, Michela Pasello, et al.. (2014). CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin. Clinical Cancer Research. 21(1). 146–156. 40 indexed citations

Macagno, Marco, Elena Quaglino, Laura Conti, et al.. (2014). Multiple Roles of Perforin in Hampering ERBB-2 (Her-2/neu) Carcinogenesis in Transgenic Male Mice. The Journal of Immunology. 192(11). 5434–5441. 16 indexed citations

Nanni, Patrizia, Giordano Nicoletti, Arianna Palladini, et al.. (2012). Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor. PLoS ONE. 7(6). e39626–e39626. 71 indexed citations

Gasparre, Giuseppe, Ivana Kurelac, Mariantonietta Capristo, et al.. (2011). A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1 , an Oncojanus Function. Cancer Research. 71(19). 6220–6229. 81 indexed citations

10.

Landuzzi, Lorena, Agnese Antognoli, Giordano Nicoletti, et al.. (2011). HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines. Vaccine. 29(29-30). 4690–4697. 4 indexed citations

11.

Manara, Maria Cristina, Giordano Nicoletti, Diana Zambelli, et al.. (2010). NVP-BEZ235 as a New Therapeutic Option for Sarcomas. Clinical Cancer Research. 16(2). 530–540. 128 indexed citations

12.

Palladini, Arianna, Giordano Nicoletti, Francesco Pappalardo, et al.. (2010). In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations. Cancer Research. 70(20). 7755–7763. 69 indexed citations

13.

Quaglino, Elena, Cristina Mastini, Augusto Amici, et al.. (2010). A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins. Cancer Research. 70(7). 2604–2612. 53 indexed citations

14.

Giovanni, Carla De, Giordano Nicoletti, Arianna Palladini, et al.. (2009). A Multi-DNA Preventive Vaccine for p53/Neu-Driven Cancer Syndrome. Human Gene Therapy. 20(5). 453–464. 9 indexed citations

15.

Nanni, Patrizia, Giordano Nicoletti, Arianna Palladini, et al.. (2007). Antimetastatic Activity of a Preventive Cancer Vaccine. Cancer Research. 67(22). 11037–11044. 32 indexed citations

16.

Iacono, Marco Lo, Federica Cavallo, Elena Quaglino, et al.. (2005). A Limited Autoimmunity to p185^neu Elicited by DNA and Allogeneic Cell Vaccine Hampers the Progression of Preneoplastic Lesions in HER-2/NEU Transgenic Mice. International Journal of Immunopathology and Pharmacology. 18(2). 351–363. 7 indexed citations

17.

Curcio, Claudia, Emma Di Carlo, Raphael Clynes, et al.. (2003). Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. Journal of Clinical Investigation. 111(8). 1161–1170. 97 indexed citations

18.

Lollini, Pier‐Luigi & Guido Forni. (2002). Antitumor vaccines: is it possible to prevent a tumor?. Cancer Immunology Immunotherapy. 51(8). 409–416. 39 indexed citations

19.

Pupa, Serenella M., Stefania Forti, Emma Di Carlo, et al.. (2001). Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination. Gene Therapy. 8(1). 75–79. 53 indexed citations

20.

Ménard, Sylvie, Piera Aiello, Elda Tagliabue, et al.. (2000). Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model.. PubMed. 60(2). 273–5. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact